| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 773.81 Million | USD 1859.75 Million | 10.2% | 2024 |
FrequentlyAsked Questions
The global pharmaceutical continuous manufacturing market is expected to grow due to increasing demand for cost-effective drug production, rising adoption of automation in pharmaceuticals, and regulatory support for continuous manufacturing processes.
According to a study, the global pharmaceutical continuous manufacturing market size was worth around USD 773.81 Million in 2024 and is expected to reach USD 1859.75 Million by 2034.
The global pharmaceutical continuous manufacturing market is expected to grow at a CAGR of 10.2% during the forecast period.
North America & Europe is expected to dominate the pharmaceutical continuous manufacturing market over the forecast period.
Leading players in the global pharmaceutical continuous manufacturing market include Coperion GmbH, Bosch Packaging Technology, Gebrüder Lödige Maschinenbau GmbH, Hosokawa Micron Corporation, GEA Group AG, Glatt GmbH, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Thermo Fisher Scientific Inc., and Munson Machinery Company Inc.,, among others.
The report explores crucial aspects of the pharmaceutical continuous manufacturing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients